BridgeBio Pharma Operating Margin 2018-2024 | BBIO

BridgeBio Pharma operating margin for the quarter ending June 30, 2024 was -233.33%.

  • BridgeBio Pharma average operating margin for 2023 was -5272.05%, a 675.39% decline from 2022.
  • BridgeBio Pharma average operating margin for 2022 was -679.92%, a 22.08% increase from 2021.
  • BridgeBio Pharma average operating margin for 2021 was -872.64%, a 54.93% decline from 2020.

Operating margin can be defined as operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc.

BridgeBio Pharma Operating Margin 2018-2024 | BBIO

  • BridgeBio Pharma average operating margin for 2023 was -5272.05%, a 675.39% decline from 2022.
  • BridgeBio Pharma average operating margin for 2022 was -679.92%, a 22.08% increase from 2021.
  • BridgeBio Pharma average operating margin for 2021 was -872.64%, a 54.93% decline from 2020.

Operating margin can be defined as operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc.